NCT03414281 is a NA clinical trial of TMQLB group 1 in Nerve Block, Nephrectomy, Analgesia, sponsored by Cui Xulei.

Who is sponsoring NCT03414281?

NCT03414281 is sponsored by Cui Xulei.

What drugs are being tested in NCT03414281?

Interventions in NCT03414281: TMQLB group 1, TMQLB group 2, TPVB.

What condition does NCT03414281 study?

NCT03414281 studies Nerve Block, Nephrectomy, Analgesia.

Is NCT03414281 still recruiting?

NCT03414281 is currently terminated. Last updated 20 March 2020.

Last reviewed 2020-03-20 · How we verify

NCT03414281

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

TMQLB Versus TPVB for Acute Pain and Quality of Recovery After Laparoscopic Renal Surgery

Terminated NA Last updated 20 March 2020

What this trial tests

NA trial testing TMQLB group 1 in Nerve Block, Nephrectomy, Analgesia in 30 participants. Terminated before completion.

Timeline

4 January 2019

Primary endpoint
1 May 2019

1 May 2019

Quick facts

Lead sponsor	Cui Xulei
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	30
Start date	4 January 2019
Primary completion	1 May 2019
Estimated completion	1 May 2019
Sites	1 location across China

Drugs / interventions tested

TMQLB group 1
TMQLB group 2
TPVB

Conditions studied

Nerve Block, Nephrectomy, Analgesia — all drugs for Nerve Block, Nephrectomy, Analgesia →

Sponsor

Cui Xulei — full company profile →

Who can join

Adults 17 to 80, any sex, with Nerve Block, Nephrectomy, Analgesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This trial is a prospective, randomized, single-center, open-label, parallel-arm, blinded-analysis trial, the objective of which is to evaluate the effect of transmuscular quadratus lumborum block (TMQLB) in the pain relief and quality of recovery in laparoscopic renal surgery compared with thoracic paravertebral block (TPVB).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Transmuscular quadratus lumborum block versus thoracic paravertebral block for acute pain and quality of recovery after laparoscopic renal surgery: study protocol for a randomized controlled trial.
Yuan Q, Cui X, Fei Y, Xu Z, et al · · 2019 · cited 12× · PMID 31109368 · DOI 10.1186/s13063-019-3359-7

Verify or expand the search:

Other Cui Xulei trials

Trials by the same sponsor.

NCT04304274 — Programmed Intermittent Bolus Infusion of Thoracic Paravertebral Block for Hepatectomy · NA · completed
NCT03990922 — CTPVB for Hepatectomy · NA · completed
NCT03975296 — QLB Versus PVB for Acute Pain and Quality of Recovery After Laparoscopic Partial Nephrectomy · NA · completed
NCT03982784 — TQLB for Postoperative Pain After Laparoscopic Partial Nephrectomy · NA · completed
NCT03777644 — Continuous Paravertebral Block on Postoperative Quality of Recovery After Hepatectomy · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03414281 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cui Xulei
Last refreshed: 20 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03414281.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing